Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia
Background: The aim of the study was to test the clinical relevance of neutralizing antibodies (NABs) in patients with cervical dystonia (CD) still responding to repeat injections with botulinum toxin type A (BoNT/A). Methods: Enzyme-linked immunosorbent assay (ELISA)-test evidence from a cross-sect...
Main Authors: | Harald Hefter, Dietmar Rosenthal, Hans Bigalke, Marek Moll |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-12-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286419892078 |
Similar Items
-
Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
by: Harald Hefter, et al.
Published: (2021-02-01) -
The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study
by: Harald Hefter, et al.
Published: (2022-01-01) -
The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia
by: Harald Hefter, et al.
Published: (2021-07-01) -
The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia
by: Sara Samadzadeh, et al.
Published: (2020-12-01) -
Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
by: Harald Hefter, et al.
Published: (2020-11-01)